BioWorld-International-2009-09-02
Strong Data Have Nitec Eying 2010 Filing in RA for Lodotra
Strong Data Have Nitec Eying 2010 Filing in RA for Lodotra
Nitec Pharma AG has obtained positive data from a second Phase III trial of Lodotra in rheumatoid arthritis (RA), paving the way for a U.S. regulatory filing next year. (BioWorld International)

